These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

560 related items for PubMed ID: 24894769

  • 1. Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation.
    Hervier B, Haroche J, Arnaud L, Charlotte F, Donadieu J, Néel A, Lifermann F, Villabona C, Graffin B, Hermine O, Rigolet A, Roubille C, Hachulla E, Carmoi T, Bézier M, Meignin V, Conrad M, Marie L, Kostrzewa E, Michot JM, Barete S, Taly V, Cury K, Emile JF, Amoura Z, French Histiocytoses Study Group.
    Blood; 2014 Aug 14; 124(7):1119-26. PubMed ID: 24894769
    [Abstract] [Full Text] [Related]

  • 2. Dramatic efficacy of dabrafenib in Erdheim-Chester disease (ECD): a pediatric patient with multiple large intracranial ECD lesions hidden by refractory Langerhans cell histiocytosis.
    Hao X, Feng R, Bi Y, Liu Y, Li C, Lu T, Tian Y.
    J Neurosurg Pediatr; 2019 Jan 01; 23(1):48-53. PubMed ID: 30265230
    [Abstract] [Full Text] [Related]

  • 3. Mixed Langerhans Cell Histiocytosis and Erdheim-Chester Disease in a Girl: A Rare and Puzzling Diagnosis.
    Ocak S, Bayramoglu Z, Tugcu D, Karaman S, Unuvar A, Karakas Z.
    J Pediatr Hematol Oncol; 2021 Apr 01; 43(3):e375-e379. PubMed ID: 32097280
    [Abstract] [Full Text] [Related]

  • 4. Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation.
    Haroche J, Cohen-Aubart F, Emile JF, Arnaud L, Maksud P, Charlotte F, Cluzel P, Drier A, Hervier B, Benameur N, Besnard S, Donadieu J, Amoura Z.
    Blood; 2013 Feb 28; 121(9):1495-500. PubMed ID: 23258922
    [Abstract] [Full Text] [Related]

  • 5. The clinical spectrum and prognostic factors of Erdheim-Chester disease and mixed Langerhans cell histiocytosis and Erdheim-Chester disease.
    Dai JW, Lin H, Chang L, Li J, Zhou DB, Cao XX.
    Ann Hematol; 2023 Dec 28; 102(12):3335-3343. PubMed ID: 37922006
    [Abstract] [Full Text] [Related]

  • 6. Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study.
    Diamond EL, Subbiah V, Lockhart AC, Blay JY, Puzanov I, Chau I, Raje NS, Wolf J, Erinjeri JP, Torrisi J, Lacouture M, Elez E, Martínez-Valle F, Durham B, Arcila ME, Ulaner G, Abdel-Wahab O, Pitcher B, Makrutzki M, Riehl T, Baselga J, Hyman DM.
    JAMA Oncol; 2018 Mar 01; 4(3):384-388. PubMed ID: 29188284
    [Abstract] [Full Text] [Related]

  • 7. Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders.
    Papo M, Cohen-Aubart F, Trefond L, Bauvois A, Amoura Z, Emile JF, Haroche J.
    Curr Oncol Rep; 2019 May 21; 21(7):62. PubMed ID: 31115724
    [Abstract] [Full Text] [Related]

  • 8. Histopathological and Clinical Findings in Cutaneous Manifestation of Erdheim-Chester Disease and Langerhans Cell Histiocytosis Overlap Syndrome Associated With the BRAFV600E Mutation.
    Liersch J, Carlson JA, Schaller J.
    Am J Dermatopathol; 2017 Jul 21; 39(7):493-503. PubMed ID: 27898473
    [Abstract] [Full Text] [Related]

  • 9. Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1.
    Gatalica Z, Bilalovic N, Palazzo JP, Bender RP, Swensen J, Millis SZ, Vranic S, Von Hoff D, Arceci RJ.
    Oncotarget; 2015 Aug 14; 6(23):19819-25. PubMed ID: 26110571
    [Abstract] [Full Text] [Related]

  • 10. BRAF V600E mutation in Juvenile Xanthogranuloma family neoplasms of the central nervous system (CNS-JXG): a revised diagnostic algorithm to include pediatric Erdheim-Chester disease.
    Picarsic J, Pysher T, Zhou H, Fluchel M, Pettit T, Whitehead M, Surrey LF, Harding B, Goldstein G, Fellig Y, Weintraub M, Mobley BC, Sharples PM, Sulis ML, Diamond EL, Jaffe R, Shekdar K, Santi M.
    Acta Neuropathol Commun; 2019 Nov 04; 7(1):168. PubMed ID: 31685033
    [Abstract] [Full Text] [Related]

  • 11. Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults.
    Milne P, Bigley V, Bacon CM, Néel A, McGovern N, Bomken S, Haniffa M, Diamond EL, Durham BH, Visser J, Hunt D, Gunawardena H, Macheta M, McClain KL, Allen C, Abdel-Wahab O, Collin M.
    Blood; 2017 Jul 13; 130(2):167-175. PubMed ID: 28512190
    [Abstract] [Full Text] [Related]

  • 12. Prospective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disorders.
    Hyman DM, Diamond EL, Vibat CR, Hassaine L, Poole JC, Patel M, Holley VR, Cabrilo G, Lu TT, Arcila ME, Chung YR, Rampal R, Lacouture ME, Rosen N, Meric-Bernstam F, Baselga J, Kurzrock R, Erlander MG, Janku F, Abdel-Wahab O.
    Cancer Discov; 2015 Jan 13; 5(1):64-71. PubMed ID: 25324352
    [Abstract] [Full Text] [Related]

  • 13. Langerhans cell histiocytosis and Erdheim-Chester disease, both with cutaneous presentations, and papillary thyroid carcinoma all harboring the BRAF(V600E) mutation.
    Johnson WT, Patel P, Hernandez A, Grandinetti LM, Huen AC, Marks S, Ho J, Monaco SE, Jaffe R, Picarsic J.
    J Cutan Pathol; 2016 Mar 13; 43(3):270-5. PubMed ID: 26454140
    [Abstract] [Full Text] [Related]

  • 14. Coexistence of intracranial Langerhans cell histiocytosis and Erdheim-Chester disease in a pediatric patient: a case report.
    Kim S, Lee M, Shin HJ, Lee J, Suh YL.
    Childs Nerv Syst; 2016 May 13; 32(5):893-6. PubMed ID: 26466952
    [Abstract] [Full Text] [Related]

  • 15. A common progenitor cell in LCH and ECD.
    Badalian-Very G.
    Blood; 2014 Aug 14; 124(7):991-2. PubMed ID: 25124781
    [Abstract] [Full Text] [Related]

  • 16. High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses.
    Haroche J, Charlotte F, Arnaud L, von Deimling A, Hélias-Rodzewicz Z, Hervier B, Cohen-Aubart F, Launay D, Lesot A, Mokhtari K, Canioni D, Galmiche L, Rose C, Schmalzing M, Croockewit S, Kambouchner M, Copin MC, Fraitag S, Sahm F, Brousse N, Amoura Z, Donadieu J, Emile JF.
    Blood; 2012 Sep 27; 120(13):2700-3. PubMed ID: 22879539
    [Abstract] [Full Text] [Related]

  • 17. [Status of Langerhans cell histiocytosis in children and adults].
    Kudo K.
    Rinsho Ketsueki; 2019 Sep 27; 60(9):1308-1316. PubMed ID: 31597857
    [Abstract] [Full Text] [Related]

  • 18. Impact of BRAFV600E mutation on aggressiveness and outcomes in adult clonal histiocytosis.
    Razanamahery J, Godot A, Leguy-Seguin V, Samson M, Audia S, Bonnotte B.
    Front Immunol; 2023 Sep 27; 14():1260193. PubMed ID: 37809108
    [Abstract] [Full Text] [Related]

  • 19. Successful treatment with cladribine of Erdheim-Chester disease with orbital and central nervous system involvement developing after treatment of Langerhans cell histiocytosis.
    Perić P, Antić B, Knezević-Usaj S, Radić-Tasić O, Radovinović-Tasić S, Vasić-Vilić J, Sekulović L, Tarabar O, Tukić L, Jovandić S, Magić Z.
    Vojnosanit Pregl; 2016 Jan 27; 73(1):83-7. PubMed ID: 26964390
    [Abstract] [Full Text] [Related]

  • 20. Histiocytic disorders: insights into novel biology and implications for therapy of Langerhans cell histiocytosis and Erdheim-Chester disease.
    McClain K.
    Hematology Am Soc Hematol Educ Program; 2020 Dec 04; 2020(1):395-399. PubMed ID: 33275721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.